loading

Finanzdaten der Eledon Pharmaceuticals Inc-Aktie (ELDN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
37.68%
24.73
17.96 24.70 20.51 14.50
Operating Income/Loss
37.68%
-24.73
-17.96 - -20.51 -14.50
Income/Loss From Continuing Operations Before Tax
72.69%
-11.22
-6.495 -44.19 76.97 -44.91
Income/Loss From Continuing Operations After Tax
72.69%
-11.22
-6.495 -44.62 76.97 -44.91
Net Income/Loss
72.69%
-11.22
-6.495 -44.62 76.97 -44.91
Preferred Stock Dividends And Other Adjustments
-
- -2.882 22.54 -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.04%
77.16
77.13 7.1007 51.95 42.28
Diluted Average Shares
0.04%
77.16
77.13 5.437 55.48 42.28
Basic Earnings Per Share
62.50%
-0.13
-0.08 -0.88 1.05 -1.06
Diluted Earnings Per Share
62.50%
-0.13
-0.08 0.67 -0.32 -1.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- -5.764 45.08 -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):